The intensive three-day scientific program which encouraged the pharmaceutical Professionals to evolve and enhance their education levels for an improved understanding of pharmaceutical care was presented through the following themes: redefining pharmacists role, upgrading quality standards, social pharmacy practice, health economics, ensuring quality use of medicines, pharmacoeconomics and medication management, protecting public health, perspectives on new technologies, quality, safety and research and clinical challenges in oral drug therapy

The conference also highlighted topics: such as Medication Safety in US Hospital and Health System Pharmacy, Role of pharmacists in safe and efficient pharmacotherapy and Quality use of medicines in hospitals, Essentials for formulary management, Challenge of oral antineoplastic therapy, etc.

DUPHAT 2015 conference will be accredited by the Society of Hospital Pharmacists of Australia (SHPA) and Dubai Health Authority (DHA)

 

DHA-Logo

 

shpa

 

Conference Topic

 

  • Ambulatory Care Clinical Pharmacy Services: Impact on Quality, Costs & Mortality
  • An overview of clinical pharmacogenetics implementation in the U.S.
  • Assuring Better Health Outcomes: Rebuilding the Academic Health Science Centre and the Opportunities for Academic Pharmacy
  • Clinical controversies in patients requiring dual anti-platelet therapy and anticoagulation
  • Continuing Professional Development – Concepts and Components
  • Continuity of Care – Comunication Among Healthcare Providers
  • Cost effectiveness of new oral anticoagulants
  • Delete the Drug from your hospital formulary because of safety concerns? Review of the Drug Safety Decisions
  • Diuretic resistance in patients with heart failure
  • Drug rediscovery: designing a ‘second live’ for existing medicines
  • Drug shortages, regulatory and policy options
  • Educating the Next Generation of Pharmacists: New Competencies for Pharmacy Education
  • Effective Management Tools to represent and establish Pharmaceutical Services
  • Emerging Therapeutic Targets in Oncology
  • Expanded role for pharmacists equal better patient care
  • Halal Medications: Issues and Challenges
  • Hospital accreditation and organisation-wide medication safety: Where do pharmacists fit?
  • In 10 Years – The Future for Pharmacy Practice
  • Medication Therapy Adherence Clinic(MTAC) towards excellence in Ambulatory Care Pharmacy Services
  • Multiple drug use – Mechanisms underlying drug combinations leading to addiction and violent behaviour
  • New guidelines
  • Online pharmacies and public awareness
  • Parkinson Disease and its Therapeutic Treatment
  • PGY3 Subspecialty Residency/Fellowship Training – The Time Has Come
  • Pharmacist Practice Systems That Improve Medication Safety For Patients
  • Pharmacists Have Learned about Personalized Medicine: Now it is Time to Learn More About P4 Medicine and Preemptive Medicine
  • Pharmacists prescribing in Canada
  • Pharmacists Services for Chronic Disease Management : Can it make a difference
  • Pharmacy Practice and Medicine Shortages
  • Pillars and Foundations of Quality in Pharmacy Education
  • Professional Marketing vs Commercial Marketing of Medicines
  • Role of the pharmacist in caring for those with addictions
  • Stakeholders Engagement for Good Governance in Pharmacy
  • Systems To Improve Medication Access: Medication “Recycling”, Vouchers And Other Programs
  • The ASHP Pharmacy Practice Model Initiative; Update -2015
  • The Future of Hospital Pharmacy around the world – Looking at the hospital pharmacists influence on prescribing and competency based training through the Basel statements’
  • The Problem of Antibiotic Overuse”
  • Use of routine health care data to inform pharmaceutical care planning and continuous quality improvement of medication use
  • What the pharmacist needs to know about addiction
  • Winning the Battle Against Counterfeit Drugs